LP Building Solutions today announced that it will release financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, Feb. 17, 2026. The company will host a live ...
These composites have a combination of desired thermal properties and performance characteristics that enable use in building ...
LP Building Solutions announced the appointment of Kaycee Casteel as Vice President of Human Resources, effective immediately ...
Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback